Delivery Order SPE2DB22D3501-SPE2DB24FUC90
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract provides for the delivery of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, with a ceiling value of $32,448.80 and a performance period through April 12, 2024. This award is a firm-fixed-price delivery order and is not designated as a...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $31,365.86 to supply TAKHZYRO 300 MG/2 ML vials. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with completion by November 2023. This order was awarded against an indefinite-delivery contract held by Amerisourcebergen with no set-aside designation specified. As a prime contractor, Amerisourcebergen regularly provides...
- The Defense Logistics Agency awarded a $31,755 delivery order to Amerisourcebergen Drug Corporation for TAKHZYRO 300 MG/2 ML syringes. Under the firm fixed price contract, Amerisourcebergen will deliver the specified pharmaceutical product to a location in Conshohocken, Pennsylvania by August 29, 2023 in support of DLA programs. No additional details were provided regarding the original solicitation or use of the products. Amerisourcebergen will perform as the prime contractor for this order...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, with a ceiling value of $33,570.26 and an ultimate completion date of December 12, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TAKHZYRO 300 MG/2 ML SYRINGE 2ML. The contract is a delivery order with a firm fixed price of $48,673.20 and an ultimate completion date of August 29, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $34,342.56 and a performance period ending on July 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a $34,342.56 delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Takhzyro 300 mg/2 ml syringes. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award through open competition. Performance is scheduled for completion by August 6, 2025, and will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Takhzyro 300 mg/2 ml syringes with a ceiling value of $34,342.56. This firm fixed-price delivery order is scheduled for completion by September 15, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract was awarded on a competitive basis with no set-aside designation. This delivery order operates under AmerisourceBergen Drug Corp's...
- This federal contract award for $32,448.80 was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, to provide TAKHZYRO 300 MG/2 ML SYRINGE 2ML. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of December 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 6, 2026, for TAKHZYRO 300 mg/2 ml syringes with a ceiling value of $18,640.57.</p> <p>Place of performance is Conshohocken, PA 19428. The order is due March 2, 2026. The delivery order is priced on a firm fixed-price basis and is issued without a set-aside.</p>
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUC90Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product TAKHZYRO 300 MG/2 ML SYRINGE 2ML, with a potential value of $16,224.40 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in support of DLA Troop Support Medical programs. This delivery order is part of Amerisourcebergen's broader contract work with the Department of Defense. No set-aside designations were used for this award, which will be performed at Amerisourcebergen's corporate office in Conshohocken, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 1/10/24 |